Marijuana Stocks

Marijuana Stocks – Industry financials and news (below).

EMBR
0.00
+0.00 (+25.00%)
EXMT
0.00
0.00 (-5.71%)
FFRMF
0.06
+0.00 (+3.54%)
GRCU
0.00
+0.00 (+12.50%)
HPNN
0.00
0.00 (-4.35%)
ICBU
0.00
0.00 (-4.76%)
IMTV
0.00
0.00 (0.00%)
ITNS
0.00
+0.00 (+20.00%)
KGET
0.00
0.00 (0.00%)
KSHB
1.36
+0.12 (+9.68%)
LVVV
0.01
+0.00 (+2.56%)
MCOA
0.01
0.00 (-24.37%)
MYDX
0.00
+0.00 (+33.33%)
MYHI
0.02
+0.00 (+8.48%)
PURA
0.01
0.00 (-3.90%)
RIGH
0.00
+0.00 (+100.00%)
SGDH
0.02
0.00 (-11.94%)
SGMD
0.00
0.00 (0.00%)
TGIFF
0.08
+0.00 (+5.98%)
USEI
0.00
+0.00 (+33.33%)
VAPE
0.00
+0.00 (+50.00%)
VDRM
0.02
-0.01 (-31.14%)
VTMB
0.00
0.00 (-16.67%)
WDRP
0.01
0.00 (-5.66%)
WTCG
0.58
+0.06 (+11.40%)
XSNX
0.44
-0.07 (-13.00%)
XTRM
0.01
0.00 (-10.00%)
APH
131.74
-2.10 (-1.57%)
ACB
12.04
+0.08 (+0.67%)
BCC
48.66
-1.02 (-2.05%)
TRST
7.22
+0.03 (+0.35%)
TLRY
19.70
+1.14 (+6.14%)
GHG
13.21
+0.18 (+1.34%)
ISOL
0.08
+0.01 (+11.43%)
LEAF
4.91
-0.16 (-3.16%)
NSP
84.90
+0.15 (+0.18%)
EAT
59.18
-1.89 (-3.09%)
OGI
1.80
0.00 (0.00%)
TER
137.30
-1.09 (-0.79%)
THC
47.38
+0.61 (+1.30%)
SUN
30.24
+0.03 (+0.10%)
ATTBF
0.01
+0.00 (+8.46%)
AERO
3.00
+0.01 (+0.33%)
BLPG
0.00
+0.00 (+9.76%)
CBDS
0.67
+0.01 (+1.21%)
CGRW
0.28
+0.08 (+36.59%)
CGRA
0.01
+0.00 (+8.33%)
DIGP
0.05
0.00 (-1.37%)
EDXC
0.14
+0.02 (+15.55%)
CANN
0.62
+0.02 (+3.10%)
GRNH
0.02
0.00 (-3.80%)
GRWC
1.26
0.00 (0.00%)
HEMP
0.01
0.00 (0.00%)
INQD
0.00
0.00 (0.00%)
PLPL
0.00
+0.00 (+66.67%)
RMHB
0.03
0.00 (-4.48%)
SMG
220.89
-3.06 (-1.37%)
SRNA
0.13
-0.07 (-34.97%)
TRTC
0.31
-0.01 (-2.15%)
TURV
0.05
0.00 (-1.89%)
ADC
63.83
+1.48 (+2.37%)
ANAS
0.05
-0.01 (-9.62%)
ERBB
0.01
0.00 (0.00%)
ARNA
80.50
-0.06 (-0.07%)
CNBX
0.32
+0.04 (+16.04%)
CBCA
0.65
-0.05 (-7.14%)
FITX
0.00
0.00 (0.00%)
CVSI
0.63
0.00 (-0.79%)
DEWM
0.00
0.00 (-7.69%)
DSCR
0.00
0.00 (-5.26%)
EAPH
0.00
0.00 (0.00%)
GERS
0.10
+0.00 (+3.38%)
GBLX
0.05
+0.01 (+17.41%)
PHOT
0.16
+0.02 (+10.71%)
LATF
0.00
0.00 (0.00%)
LXRP
0.22
-0.03 (-10.68%)
MDCN
0.00
0.00 (0.00%)
MJNA
0.03
0.00 (-2.69%)
MNTR
0.13
+0.01 (+5.78%)
NCAP
0.00
0.00 (0.00%)
NGBL
0.00
0.00 (0.00%)
NDEV
0.06
0.00 (0.00%)
PUGE
0.00
0.00 (-11.84%)
SIPC
0.01
+0.00 (+0.43%)
STEV
0.00
0.00 (-7.32%)
VPOR
0.00
0.00 (0.00%)
VAPR
0.01
+0.00 (+4.40%)
ALGWF
0.01
0.00 (0.00%)
BLOZF
0.94
-0.05 (-4.77%)
CGC
33.39
-1.23 (-3.55%)
CRON
10.93
-0.33 (-2.93%)
EMHTF
0.20
0.00 (-0.96%)
FUAPF
0.14
+0.00 (+0.28%)
GLDFF
0.02
0.00 (-3.77%)
HRVOF
0.08
+0.01 (+8.78%)
HHPHF
0.01
0.00 (0.00%)
ITHUF
0.31
+0.00 (+1.13%)
LTTSF
0.13
0.00 (-0.84%)
LHSIF
0.95
-0.05 (-5.32%)
LIBFF
0.19
+0.01 (+2.72%)
MMJFF
0.04
+0.00 (+10.38%)
MYMMF
0.09
+0.00 (+3.01%)
AGFAF
0.03
0.00 (-1.87%)
RDDTF
0.08
-0.01 (-6.98%)
SOLCF
2.72
-0.02 (-0.87%)
SPRWF
0.17
+0.00 (+0.66%)
TBPMF
0.15
0.00 (-1.21%)
TNYBF
0.33
+0.00 (+0.43%)
VRTHF
0.11
0.00 (0.00%)
VDQSF
0.04
0.00 (0.00%)
WDDMF
0.27
+0.02 (+7.58%)
CARA
18.56
+0.51 (+2.83%)
GWPRF
11.30
-0.20 (-1.74%)
VPRB
0.03
+0.01 (+25.99%)
ZYNE
3.59
-0.06 (-1.64%)
OPMZ
0.00
+0.00 (+133.33%)
XXII
2.78
-0.07 (-2.46%)
FTPM
0.00
0.00 (0.00%)
ABBV
110.52
-1.11 (-0.99%)
ACCA
0.04
0.00 (-9.52%)
RSSFF
0.03
0.00 (0.00%)
AGTK
0.02
0.00 (-8.00%)
AMMJ
0.15
+0.03 (+30.15%)
ACAN
1.25
+0.10 (+8.70%)
APPB
0.08
0.00 (0.00%)
ASBFY
30.46
-0.28 (-0.91%)
AXIM
0.47
-0.01 (-2.68%)
BE
36.47
-2.39 (-6.15%)
CPMD
0.44
-0.04 (-8.33%)
CLSH
0.17
+0.01 (+3.16%)
CODI
21.45
+0.20 (+0.94%)
CRBP
1.74
0.00 (0.00%)
DPWW
0.01
0.00 (-0.91%)
ETST
0.03
+0.00 (+16.12%)
SEED
18.13
+0.18 (+1.00%)
FUTL
0.00
0.00 (0.00%)
GBHPF
0.03
+0.01 (+28.57%)
GRSO
0.00
+0.00 (+85.00%)
GRWG
51.11
+0.63 (+1.25%)
GWPH
135.73
-2.10 (-1.52%)
HLSPY
0.38
+0.00 (+1.05%)
HMPQ
0.00
0.00 (-10.71%)
IGC
1.53
-0.02 (-1.29%)
IIPR
189.30
-0.47 (-0.25%)
NTEC
4.13
-0.21 (-4.84%)
GENE
4.17
-0.26 (-5.87%)
KAYS
0.54
+0.50 (+1,282.84%)
LBUY
0.16
0.00 (0.00%)
MGWFF
0.05
0.00 (-0.22%)
MRMD
0.80
0.00 (-0.18%)
MBII
1.53
+0.18 (+13.33%)
MSRT
0.03
+0.01 (+42.97%)
MJNE
0.44
+0.03 (+8.64%)
MPX
15.74
-0.27 (-1.69%)
NSPDF
0.05
+0.01 (+24.04%)
NTRR
0.00
+0.00 (+19.23%)
USMJ
0.00
0.00 (0.00%)
NUVG
0.02
0.00 (-7.69%)
OWCP
0.01
0.00 (-13.71%)
VIDA
0.00
0.00 (0.00%)
PNPL
0.09
0.00 (0.00%)
PRRE
0.08
+0.00 (+4.02%)
PMD
4.95
-0.15 (-2.94%)
WDLF
0.00
+0.00 (+18.18%)
VFF
12.65
-1.70 (-11.85%)
ZDPY
0.40
+0.00 (+0.03%)
APHA
12.42
+0.31 (+2.56%)
ACNNF
0.15
+0.00 (+1.33%)
SARSF
0.03
0.00 (-2.77%)
CRXPF
0.02
+0.00 (+2.17%)
ELLXF
0.17
+0.00 (+1.20%)
6924.T
1,429.00
-1.00 (-0.07%)
YCBD
3.94
0.00 (0.00%)
MICWF
0.12
-0.03 (-18.24%)
NXTTF
0.26
-0.07 (-21.49%)
EMBI
0.09
+0.00 (+1.69%)
NRXCF
0.10
+0.00 (+3.35%)
SPLIF
0.01
0.00 (-21.74%)
RVVTF
0.49
0.00 (-0.55%)
Last updated: January 19, 2021 @ 02:41:54
Symbol Company Last
Price
Change % Chg Volume Market Cap
EMBR PNK
Embarr Downs, Inc.
0.00 +0.00 +25.00% 3,026,600 5,374
EXMT PNK
Anything Technologies Media, Inc.
Telecom Services
0.00 0.00 -5.71% 33,347,662 185,733
FFRMF PNK
Future Farm Technologies Inc.
Farm Products
0.06 +0.00 +3.54% 498,711 9,992,560
GRCU PNK
Green Cures & Botanical Distribution Inc.
Drug Manufacturers - Specialty & Generic
0.00 +0.00 +12.50% 15,625,655 4,853,736
HPNN PNK
Hop-On Inc.
Communication Equipment
0.00 0.00 -4.35% 168,167,678 16,385,710
ICBU PNK
iMD Companies, Inc.
0.00 0.00 -4.76% 16,285,389 47,080
IMTV PNK
Imagination TV, Inc.
0.00 0.00 0.00% 7,552,000 1,221
ITNS PNK
Itonis, Inc.
0.00 +0.00 +20.00% 581,317 249,860
KGET PNK
CaliPharms, Inc.
0.00 0.00 0.00% 501,400 401,297
KSHB PNK
KushCo Holdings, Inc.
Packaging & Containers
1.36 +0.12 +9.68% 2,308,592 179,713,120
LVVV PNK
Livewire Ergogenics, Inc.
Drug Manufacturers - Specialty & Generic
0.01 +0.00 +2.56% 11,429,872 9,547,760
MCOA PNK
Marijuana Company of America, Inc.
0.01 0.00 -24.37% 496,527,423 12,447,876
MYDX PNK
MyDx, Inc.
0.00 +0.00 +33.33% 72,747,879 2,360,503
MYHI PNK
Mountain High Acquisitions Corp.
Drug Manufacturers - Specialty & Generic
0.02 +0.00 +8.48% 978,727 11,240,225
PURA PNK
Puration, Inc.
Pollution & Treatment Controls
0.01 0.00 -3.90% 13,072,465 8,441,180
RIGH PNK
Bud Genius, Inc.
0.00 +0.00 +100.00% 26,788,606 158,565
SGDH PNK
SGD Holdings, Ltd.
0.02 0.00 -11.94% 189,083 34,202,068
SGMD PNK
Sugarmade, Inc.
0.00 0.00 0.00% 15,131,990 4,965,824
TGIFF PNK
1933 Industries Inc.
Drug Manufacturers - Specialty & Generic
0.08 +0.00 +5.98% 1,687,388 24,632,628
USEI PNK
U.S. Energy Initiatives Corporation Inc.
0.00 +0.00 +33.33% 51,506,619 239,966
VAPE PNK
Vape Holdings, Inc.
0.00 +0.00 +50.00% 402,746 300,000
VDRM PNK
ViaDerma, Inc.
0.02 -0.01 -31.14% 157,494,689 83,766
VTMB PNK
Vitamin Blue, Inc.
Leisure
0.00 0.00 -16.67% 1,000,000 470,043
WDRP PNK
Wanderport Corporation
Food Distribution
0.01 0.00 -5.66% 1,065,726 20,667
WTCG PNK
W Technologies, Inc.
0.58 +0.06 +11.40% 3,600 14,655
XSNX PNK
NovAccess Global Inc.
0.44 -0.07 -13.00% 5,832 696,817
XTRM PNK
Extreme Biodiesel, Inc.
0.01 0.00 -10.00% 42,802,965 652,283
APH NYQ
Amphenol Corporation
Electronic Components
131.74 -2.10 -1.57% 1,312,597 39,410,683,904
ACB NYQ
Aurora Cannabis Inc.
Drug Manufacturers - Specialty & Generic
12.04 +0.08 +0.67% 45,172,968 2,221,476,352
BCC NYQ
Boise Cascade Company
Lumber & Wood Production
48.66 -1.02 -2.05% 371,693 1,907,530,368
TRST NMS
TrustCo Bank Corp NY
Banks - Regional - US
7.22 +0.03 +0.35% 604,052 695,761,984
TLRY NMS
Tilray, Inc.
Drug Manufacturers - Specialty & Generic
19.70 +1.14 +6.14% 98,370,129 3,117,662,976
GHG NYQ
GreenTree Hospitality Group Ltd.
Lodging
13.21 +0.18 +1.34% 9,196 1,349,784,576
ISOL PNK
1mage Software, Inc.
Software - Application
0.08 +0.01 +11.43% 6,000 165,129
LEAF NYQ
Leaf Group Ltd.
Internet Content & Information
4.91 -0.16 -3.16% 280,718 169,567,328
NSP NYQ
Insperity, Inc.
Staffing & Outsourcing Services
84.90 +0.15 +0.18% 162,333 3,256,263,168
EAT NYQ
Brinker International, Inc.
Restaurants
59.18 -1.89 -3.09% 1,290,085 2,680,226,816
OGI NMS
OrganiGram Holdings Inc.
Drug Manufacturers - Specialty & Generic
1.80 0.00 0.00% 21,183,426 422,051,360
TER NMS
Teradyne, Inc.
Semiconductor Equipment & Materials
137.30 -1.09 -0.79% 1,734,043 22,799,489,024
THC NYQ
Tenet Healthcare Corporation
Medical Care
47.38 +0.61 +1.30% 808,586 4,999,395,328
SUN NYQ
Sunoco LP
Oil & Gas Refining & Marketing
30.24 +0.03 +0.10% 335,582 3,008,873,984
ATTBF PNK
Abattis Bioceuticals Corp.
Drug Manufacturers - Specialty & Generic
0.01 +0.00 +8.46% 1,037,392 6,737,036
AERO PNK
Aerogrow International, Inc.
Home Improvement Stores
3.00 +0.01 +0.33% 14,375 102,984,000
BLPG PNK
Blue Line Protection Group, Inc.
Security & Protection Services
0.00 +0.00 +9.76% 19,231,482 3,700,606
CBDS PNK
Cannabis Sativa, Inc.
Drug Manufacturers - Specialty & Generic
0.67 +0.01 +1.21% 286,531 18,188,826
CGRW PNK
CannaGrow Holdings, Inc
Business Services
0.28 +0.08 +36.59% 783,034 28,356,720
CGRA PNK
CGrowth Capital, Inc.
Oil & Gas E&P
0.01 +0.00 +8.33% 1,149,999 70,649
DIGP PNK
DigiPath, Inc.
0.05 0.00 -1.37% 218,532 2,707,796
EDXC PNK
CBD Unlimited, Inc.
Drug Manufacturers - Specialty & Generic
0.14 +0.02 +15.55% 2,329,886 31,996,114
CANN PNK
General Cannabis Corp
Security & Protection Services
0.62 +0.02 +3.10% 705,640 36,953,512
GRNH PNK
GreenGro Technologies, Inc.
Industrial Distribution
0.02 0.00 -3.80% 17,904,867 9,127,823
GRWC PNK
Grow Capital, Inc.
1.26 0.00 0.00% 19,937 28,597,716
HEMP PNK
Hemp, Inc
Farm Products
0.01 0.00 0.00% 97,513,028 31,065,938
INQD PNK
Indoor Harvest Corp.
0.00 0.00 0.00% 21,112,635 7,482,720
PLPL PNK
Plandaí Biotechnology, Inc.
Biotechnology
0.00 +0.00 +66.67% 347,737,770 236,874
RMHB PNK
Rocky Mountain High Brands, Inc.
0.03 0.00 -4.48% 1,468,527 9,271,456
SMG NYQ
The Scotts Miracle-Gro Company
Agricultural Inputs
220.89 -3.06 -1.37% 207,669 12,301,076,480
SRNA PNK
Surna Inc.
Farm & Construction Equipment
0.13 -0.07 -34.97% 21,167,385 30,748,510
TRTC PNK
Terra Tech Corp.
Farm & Construction Equipment
0.31 -0.01 -2.15% 7,367,842 59,017,472
TURV PNK
Two Rivers Water & Farming Company
Farm & Construction Equipment
0.05 0.00 -1.89% 513,107 4,779,478
ADC NYQ
Agree Realty Corporation
REIT - Retail
63.83 +1.48 +2.37% 351,677 4,022,662,400
ANAS PNK
Alternaturals, Inc.
Drug Manufacturers - Specialty & Generic
0.05 -0.01 -9.62% 204,687 1,045,096
ERBB PNK
American Green, Inc.
Drug Manufacturers - Specialty & Generic
0.01 0.00 0.00% 93,977,605 154,638,640
ARNA NMS
Arena Pharmaceuticals, Inc.
Biotechnology
80.50 -0.06 -0.07% 471,294 4,682,202,112
CNBX PNK
Cannabics Pharmaceuticals Inc.
Biotechnology
0.32 +0.04 +16.04% 808,892 43,938,828
CBCA PNK
Crown Baus Capital Corp.
Conglomerates
0.65 -0.05 -7.14% 2,074 60,291,008
FITX PNK
Creative Edge Nutrition, Inc.
Drug Manufacturers - Specialty & Generic
0.00 0.00 0.00% 2,050,292 568,499
CVSI PNK
CV Sciences, Inc.
Drug Manufacturers - Specialty & Generic
0.63 0.00 -0.79% 1,321,671 62,511,876
DEWM PNK
Dewmar International BMC, Inc.
Marketing Services
0.00 0.00 -7.69% 908,400 1,709,166
DSCR PNK
Discovery Minerals Ltd.
Industrial Metals & Minerals
0.00 0.00 -5.26% 243,193,378 4,488,219
EAPH PNK
Easton Pharmaceuticals Inc.
Drug Manufacturers - Specialty & Generic
0.00 0.00 0.00% 167,500 115,499
GERS PNK
GreenShift Corporation
Waste Management
0.10 +0.00 +3.38% 7,541 77,741,928
GBLX PNK
GB Sciences, Inc.
Biotechnology
0.05 +0.01 +17.41% 1,338,404 14,060,772
PHOT PNK
GrowLife, Inc.
Industrial Distribution
0.16 +0.02 +10.71% 1,241,630 6,930,949
LATF PNK
Latteno Food Corp.
Packaged Foods
0.00 0.00 0.00% 22,275,580 2,065,139
LXRP PNK
Lexaria Bioscience Corp.
Packaged Foods
0.22 -0.03 -10.68% 2,151,506 16,599,150
MDCN PNK
Medican Enterprises, Inc.
Drug Manufacturers - Specialty & Generic
0.00 0.00 0.00% 50,685,468 13,479
MJNA PNK
Medical Marijuana, Inc.
0.03 0.00 -2.69% 58,629,870 56,487,560
MNTR PNK
Mentor Capital, Inc.
Capital Markets
0.13 +0.01 +5.78% 432,918 2,970,617
NCAP PNK
Northsight Capital, Inc.
0.00 0.00 0.00% 1,147,500 119,004
NGBL PNK
Notis Global, Inc.
Drug Manufacturers - Specialty & Generic
0.00 0.00 0.00% 12,646,728 1,000,000
NDEV PNK
Novus Acquisition & Development Corp.
Insurance - Diversified
0.06 0.00 0.00% 89,678 6,262,630
PUGE PNK
Puget Technologies, Inc.
0.00 0.00 -11.84% 202,667,865 349,405
SIPC PNK
Sipp Industries, Inc.
Business Services
0.01 +0.00 +0.43% 3,897,800 759,226
STEV PNK
Stevia Corp.
Farm Products
0.00 0.00 -7.32% 722,234 4,004,440
VPOR PNK
Vapor Group, Inc.
Tobacco
0.00 0.00 0.00% 2,913,187 3,551,650
VAPR PNK
VaporBrands International, Inc.
Tobacco
0.01 +0.00 +4.40% 537,000 0
ALGWF PNK
Alliance Growers Corp.
Drug Manufacturers - Specialty & Generic
0.01 0.00 0.00% 52 1,312,430
BLOZF PNK
Cannabix Technologies Inc.
Medical Devices
0.94 -0.05 -4.77% 523,290 98,899,280
CGC NMS
Canopy Growth Corporation
Drug Manufacturers - Specialty & Generic
33.39 -1.23 -3.55% 7,811,799 12,554,171,392
CRON NGM
Cronos Group Inc.
Drug Manufacturers - Specialty & Generic
10.93 -0.33 -2.93% 9,244,331 3,925,422,336
EMHTF PNK
Emerald Health Therapeutics, Inc.
Drug Manufacturers - Specialty & Generic
0.20 0.00 -0.96% 612,876 39,712,304
FUAPF PNK
Global Cannabis Applications Corp.
Health Information Services
0.14 +0.00 +0.28% 291,931 22,023,868
GLDFF PNK
Golden Leaf Holdings Ltd.
Drug Manufacturers - Specialty & Generic
0.02 0.00 -3.77% 1,422,163 20,943,178
HRVOF PNK
Harvest One Cannabis Inc.
Drug Manufacturers - Specialty & Generic
0.08 +0.01 +8.78% 557,560 17,853,964
HHPHF PNK
Mojave Jane Brands Inc.
Drug Manufacturers - Specialty & Generic
0.01 0.00 0.00% 500 900,307
ITHUF PNK
iAnthus Capital Holdings, Inc.
Drug Manufacturers - Specialty & Generic
0.31 +0.00 +1.13% 1,774,498 54,302,808
LTTSF PNK
Lotus Ventures Inc.
Conglomerates
0.13 0.00 -0.84% 11,410 10,758,188
LHSIF PNK
Liberty Health Sciences Inc.
Drug Manufacturers - Specialty & Generic
0.95 -0.05 -5.32% 1,641,074 331,071,296
LIBFF PNK
Nova Mentis Life Science Corp.
Drug Manufacturers - Specialty & Generic
0.19 +0.01 +2.72% 161,364 11,792,265
MMJFF PNK
Matica Enterprises Inc.
Drug Manufacturers - Specialty & Generic
0.04 +0.00 +10.38% 55,176 12,594,471
MYMMF PNK
MYM Nutraceuticals Inc.
Biotechnology
0.09 +0.00 +3.01% 453,174 18,768,172
AGFAF PNK
AgraFlora Organics International Inc.
Drug Manufacturers - Specialty & Generic
0.03 0.00 -1.87% 1,286,747 47,144,160
RDDTF PNK
Radient Technologies Inc.
Pollution & Treatment Controls
0.08 -0.01 -6.98% 187,781 28,693,064
SOLCF PNK
SOL Global Investments Corp.
Drug Manufacturers - Specialty & Generic
2.72 -0.02 -0.87% 292,935 147,583,904
SPRWF PNK
The Supreme Cannabis Company, Inc.
Drug Manufacturers - Specialty & Generic
0.17 +0.00 +0.66% 6,219,291 81,028,736
TBPMF PNK
Tetra Bio-Pharma Inc.
Biotechnology
0.15 0.00 -1.21% 188,428 43,448,212
TNYBF PNK
The Tinley Beverage Company Inc.
Beverages - Wineries & Distilleries
0.33 +0.00 +0.43% 138,247 38,670,236
VRTHF PNK
Veritas Pharma Inc.
Drug Manufacturers - Specialty & Generic
0.11 0.00 0.00% 4,060 1,761,433
VDQSF PNK
Gnomestar Craft Inc.
Industrial Distribution
0.04 0.00 0.00% 1,000 2,873,588
WDDMF PNK
WeedMD Inc.
Drug Manufacturers - Specialty & Generic
0.27 +0.02 +7.58% 308,433 57,348,916
CARA NGM
Cara Therapeutics, Inc.
Biotechnology
18.56 +0.51 +2.83% 523,942 924,883,776
GWPRF PNK
GW Pharmaceuticals plc
Drug Manufacturers - Major
11.30 -0.20 -1.74% 4,593 4,228,245,248
VPRB PNK
VPR Brands, LP
Tobacco
0.03 +0.01 +25.99% 2,729,733 2,506,978
ZYNE NMS
Zynerba Pharmaceuticals, Inc.
Biotechnology
3.59 -0.06 -1.64% 1,280,936 105,686,728
OPMZ PNK
1PM Industries, Inc.
0.00 +0.00 +133.33% 2,370,705,945 262,924
XXII ASE
22nd Century Group, Inc.
Biotechnology
2.78 -0.07 -2.46% 1,712,998 386,028,032
FTPM PNK
420 Property Management, Inc.
0.00 0.00 0.00% 1,015,110 446,000
ABBV NYQ
AbbVie Inc.
110.52 -1.11 -0.99% 9,096,982 195,048,996,864
ACCA PNK
Acacia Diversified Holdings, Inc.
0.04 0.00 -9.52% 11,633,427 2,062,765
RSSFF PNK
Affinor Growers Inc.
Farm Products
0.03 0.00 0.00% 18,702 4,583,656
AGTK PNK
Agritek Holdings, Inc.
0.02 0.00 -8.00% 337,897 381,571
AMMJ PNK
American Cannabis Company, Inc.
0.15 +0.03 +30.15% 3,368,411 9,198,435
ACAN PNK
AmeriCann, Inc.
1.25 +0.10 +8.70% 133,626 29,620,376
APPB PNK
Applied Biosciences Corp.
Drug Manufacturers - Specialty & Generic
0.08 0.00 0.00% 3,250 1,128,080
ASBFY PNK
Associated British Foods plc
Packaged Foods
30.46 -0.28 -0.91% 2,543 24,360,476,672
AXIM PNK
AXIM Biotechnologies, Inc.
0.47 -0.01 -2.68% 75,892 59,092,984
BE NYQ
Bloom Energy Corporation
Utilities - Independent Power Producers
36.47 -2.39 -6.15% 4,844,906 6,061,241,344
CPMD PNK
CannaPharmaRX, Inc.
Conglomerates
0.44 -0.04 -8.33% 47,500 18,767,936
CLSH PNK
CLS Holdings USA, Inc.
0.17 +0.01 +3.16% 52,802 20,884,216
CODI NYQ
Compass Diversified
21.45 +0.20 +0.94% 177,785 1,392,105,088
CRBP NGM
Corbus Pharmaceuticals Holdings, Inc.
Biotechnology
1.74 0.00 0.00% 11,879,263 146,224,736
DPWW PNK
Diego Pellicer Worldwide, Inc.
0.01 0.00 -0.91% 1,527,664 2,162,908
ETST PNK
Earth Science Tech, Inc.
0.03 +0.00 +16.12% 306,640 1,489,213
SEED NMS
Origin Agritech Limited
Agricultural Inputs
18.13 +0.18 +1.00% 394,397 90,862,480
FUTL PNK
FutureLand, Corp.
Real Estate Services
0.00 0.00 0.00% 88,661,330 2,686,503
GBHPF PNK
Global Hemp Group Inc.
Agricultural Inputs
0.03 +0.01 +28.57% 715,952 5,207,463
GRSO PNK
Grow Solutions Holdings, Inc.
0.00 +0.00 +85.00% 896,839,353 507,987
GRWG NMS
GrowGeneration Corp.
Industrial Distribution
51.11 +0.63 +1.25% 3,860,243 2,797,255,424
GWPH NMS
GW Pharmaceuticals plc
Drug Manufacturers - Major
135.73 -2.10 -1.52% 379,971 4,228,247,296
HLSPY PNK
Heliospectra AB (publ)
Electronic Components
0.38 +0.00 +1.05% 18,038 23,347,354
HMPQ PNK
HempAmericana, Inc
0.00 0.00 -10.71% 32,724,276 259,752
IGC ASE
India Globalization Capital, Inc.
1.53 -0.02 -1.29% 1,682,998 65,460,132
IIPR NYQ
Innovative Industrial Properties, Inc.
189.30 -0.47 -0.25% 498,948 4,197,614,080
NTEC NCM
Intec Pharma Ltd
Biotechnology
4.13 -0.21 -4.84% 581,691 16,306,190
GENE NMS
Genetic Technologies Limited
Diagnostics & Research
4.17 -0.26 -5.87% 874,686 64,240,104
KAYS PNK
Kaya Holdings, Inc.
0.54 +0.50 +1,282.84% 17,902 7,702,614
LBUY PNK
Leafbuyer Technologies, Inc.
0.16 0.00 0.00% 242,297 13,146,310
MGWFF PNK
Maple Leaf Green World Inc.
0.05 0.00 -0.22% 267,633 8,929,494
MRMD PNK
MariMed Inc.
Biotechnology
0.80 0.00 -0.18% 3,298,164 240,333,600
MBII NCM
Marrone Bio Innovations, Inc.
1.53 +0.18 +13.33% 1,749,764 256,241,328
MSRT PNK
MassRoots, Inc.
0.03 +0.01 +42.97% 39,094,569 13,552,780
MJNE PNK
MJ Holdings, Inc.
0.44 +0.03 +8.64% 427,856 28,932,772
MPX NYQ
Marine Products Corporation
Recreational Vehicles
15.74 -0.27 -1.69% 21,901 533,091,744
NSPDF PNK
Naturally Splendid Enterprises Ltd.
Biotechnology
0.05 +0.01 +24.04% 5,690 10,367,472
NTRR PNK
Neutra Corp.
Biotechnology
0.00 +0.00 +19.23% 67,360,021 4,289,067
USMJ PNK
North American Cannabis Holdings, Inc.
Drug Manufacturers - Specialty & Generic
0.00 0.00 0.00% 52,857,459 9,984
NUVG PNK
Nuvus Gro Corp.
Scientific & Technical Instruments
0.02 0.00 -7.69% 3,636 1,336,898
OWCP PNK
OWC Pharmaceutical Research Corp.
Drug Manufacturers - Specialty & Generic
0.01 0.00 -13.71% 8,566,816 5,323,228
VIDA PNK
Vidaroo Corp
Pay TV
0.00 0.00 0.00% 111,867 60,709
PNPL PNK
Pineapple, Inc.
Business Services
0.09 0.00 0.00% 709 47,563,704
PRRE PNK
Praetorian Property, Inc.
0.08 +0.00 +4.02% 21,965 143,527,504
PMD NMS
Psychemedics Corporation
Diagnostics & Research
4.95 -0.15 -2.94% 27,689 27,356,124
WDLF PNK
Social Life Network, Inc.
0.00 +0.00 +18.18% 386,830,877 8,986,068
VFF NMS
Village Farms International, Inc.
Farm Products
12.65 -1.70 -11.85% 10,484,185 842,920,064
ZDPY PNK
Zoned Properties, Inc.
0.40 +0.00 +0.03% 103 4,803,398
APHA NMS
Aphria Inc.
Drug Manufacturers - Specialty & Generic
12.42 +0.31 +2.56% 53,879,826 3,961,532,928
ACNNF PNK
AusCann Group Holdings Ltd
Drug Manufacturers - Specialty & Generic
0.15 +0.00 +1.33% 40,020 46,839,404
SARSF PNK
Canada House Wellness Group Inc.
Industrial Distribution
0.03 0.00 -2.77% 14,000 5,600,816
CRXPF PNK
Vert Infrastructure Ltd.
Real Estate Services
0.02 +0.00 +2.17% 5,503 269,453
ELLXF PNK
Elixinol Global Limited
Drug Manufacturers - Specialty & Generic
0.17 +0.00 +1.20% 136,836 46,294,676
6924.T JPX
Iwasaki Electric Co., Ltd.
1,429.00 -1.00 -0.07% 16,600 10,842,223,616
YCBD ASE
cbdMD, Inc.
3.94 0.00 0.00% 1,746,551 205,395,744
MICWF PNK
Beyond Medical Technologies Inc.
Pollution & Treatment Controls
0.12 -0.03 -18.24% 65,631 6,199,462
NXTTF PNK
Namaste Technologies Inc.
Specialty Retail
0.26 -0.07 -21.49% 4,737,286 86,375,464
EMBI PNK
Emerald Bioscience Inc.
0.09 +0.00 +1.69% 6,962,748 22,506,660
NRXCF PNK
NeutriSci International Inc.
Drug Manufacturers - Specialty & Generic
0.10 +0.00 +3.35% 25,631 14,817,141
SPLIF PNK
Nutritional High International Inc.
Drug Manufacturers - Specialty & Generic
0.01 0.00 -21.74% 2,529,839 4,617,783
RVVTF PNK
Revive Therapeutics Ltd.
Biotechnology
0.49 0.00 -0.55% 1,180,890 112,321,152
Last updated: January 19, 2021 @ 02:41:55

Market News - January 19, 2021

Aphria's stock soars after reporting surprise profit, giving a boost to merger partner Tilray

The U.S.-listed shares of Aphria Inc. shot up 17% in midday trading Thursday toward a more-than two-year high, after the Canada-based cannabis company reported a surprise fiscal second-quarter adjusted profit and revenue that rose above forecasts, citing strength in its global cannabis and consumer packaged goods businesses. The net loss for the quarter to Nov. 30 widened to C$122.0 million ($96.3 million), or 42 cents a share, from C$8.2 million, or 3 cents a share, in the year-ago period. Excluding non-recurring items, the company swung to EPS of 1 cent from a loss of 19 cents, beating the FactSet consensus for a per-share loss of 3 cents. Revenue rose 33% to C$160.5 million ($126.6 million), above the FactSet consensus of C$153.9 million. Adult-use cannabis revenue rose 149% to C$72.1 million. The average selling price of adult-use cannabis rose to C$4.29 per gram from C$4.15 per gram in the previous quarter, while the average retail selling price of medical cannabis fell to C$6.96 per gram from C$7.38 per gram. Shares of Tilray Inc. jumped 19.4%, as the company and Aphria agreed in December to a merger. The stock, which which is on track for the highest close since November 2018, has soared 98.6% over the past three months while the ETFMG Alternative Harvest ETF has climbed 72.4% and the S&P 500 has gained 9.4%.

OrganiGram stock drops after cannabis company reports wider loss, revenue miss

The U.S.-listed shares of OrganiGram Holdings Inc. dropped 2.3% in premarket trading, as the Canada-based cannabis company reported a much wider fiscal first-quarter net loss and net revenue that fell more than forecast, while adult-use recreational cannabis revenue jumped. The net loss for the quarter to Nov. 30 increased to C$34.3 million ($26.9 million) from about C$863,000 in the same period a year ago. The FactSet consensus for net losses was C$7.1 million. Gross revenue fell 11% to C$25.3 million ($19.8 million), while net revenue, which includes excise taxes, dropped 23% to C$19.3 million. The FactSet revenue consensus was C$20.3 million. Adult-use recreational net revenue rose 30% to C$16.8 million. Gross margin swung to a negative C$16.7 million from positive C$11.2 million. "We are pleased with our double-digit sales growth in the Canadian adult-use recreational market this past quarter as it reflects the success of many of our new product launches, particularly in the dried flower value segment," said Chief Executive Greg Engel. The company said the annualized run rate for adult use cannabis sales rose to a record $3.2 billion in October, based on data from Statistics Canada. The stock has soared 42.7% over the past three months through Monday, while the ETFMG Alternative Harvest ETF has hiked up 47.3% and the S&P 500 has gained 7.5%.

GW Pharmaceuticals provides upbeat total and Epidiolex sales outlooks; stock turns up

GW Pharmaceuticals PLC provided an upbeat outlook for fourth-quarter sales, amid strength in sales of Epidiolex, the first cannabis-based drug to be approved by the Food and Drug Administration. The stock edged up 0.2% in premarket trading, reversing earlier losses. The company now expects total product sales of $148 million, above the FactSet consensus of $141.2 million, as Epidiolex sales are expected to be $144 million, which is above expectations of $137.4 million. The company said Epidiolex sales have increased by 70% in 2020, despite challenges associated with the COVID-19 pandemic. "Our goals in 2021 include driving further Epidiolex growth and advancing multiple US pivotal trials for nabiximols in the treatment of [multiple sclerosis] spasticity, with the first data readout expected this year," said Chief Executive Justin Grover. The stock has run up 35.4% over the past three months through Friday, while the ETFMG Alternative Harvest ETF has soared 45.6% and the S&P 500 has gained 10.0%.

Cannabis-industry investors ‘are likely overestimating the odds for federal decriminalization,’ analyst says

While cannabis stocks soar this week after Democratic wins in Georgia's runoffs put the party in control of the U.S. Senate, one analyst warns the rally looks overdone.

'Blue Wave' Lifting These ETFs

With Democrats in control of the House, Senate and White House, some sectors will benefit better than others.

5 high-growth themes and the stock-market ETFs that can deliver big gains in 2021

Wall Street closed the books on 2020 with a decidedly good year for U.S. stocks. Lagging even farther behind was the Dow Jones Industrial Average (DJIA) up only 7% on the year. The root cause lies in the fact that the Nasdaq-100 has more than 40% of its assets in tech and only about 2% in financial services.

Implications for markets from the Georgia runoff results

Isaac Boltansky, director of policy research at Compass Point Research & Trading, joins Yahoo Finance Live to discuss the winners and losers in different electoral scenarios from the Georgia Senate runoff, as well as the three areas he’s focused on from President-elect Joe Biden’s agenda.

UPDATE: Cannabis stocks stage strong premarket rally on hopes the pro-reform Democrats may take the Senate

Cannabis stocks rallied in premarket trade Wednesday, on hopes the Democrats may take the Senate after Raphael Warnock won one of two Senate runoffs in Georgia early Wednesday, according to the Associated Press, bringing Democrats a seat closer to a Senate majority. With 97% of the expected vote total reported, Democratic challenger Jon Ossoff was leading Republican Sen. David Perdue by just 0.22 percentage points, according to data aggregated by the Associated Press. Democrats are expected to pursue a more cannabis reform agenda under President-elect Joe Biden and Vice President-elect Kamala Harris, who have been more supportive of opening the banking sector and other needed services to the industry, which has been hampered by the tricky regulatory backdrop that has allowed the black market to continue to flourish. "We go from speculating what President-elect Biden could have done for cannabis reform via Executive Order (or by directives/"memos" from his incoming Attorney General) and if the Senate would have held a vote on the SAFE act (banking reform) would have even taken a vote, to a new world, in which the question is more about the timing and scope of much broader reform for the cannabis industry," Cantor Fitzgerald analyst Pablo Zuanic wrote in a note to clients.The ETFMG Alternative Harvest ETF was up about 7% premarket, while the Cannabis ETF was up 1.1%. Among individual stocks, U.S.-listed shares of Aurora Cannabis Inc. , the most widely held stock on the Robinhood trading app, were up 15%. Tilray Inc. was up 15.4%, Canopy Growth Corp.s [c: ca:weed] was up 8% and Cronos Group Inc. was up 10%. The Cannabis ETF has gained 63% in the last three months, while the S&P 500 has gained 11%.

The 7 Best ETFs For Marijuana Bulls To Buy Right Now

Helped by Election Day results in the U.S., marijuana stocks are experiencing a renaissance of late. It’s not yet a replay of 2018, but plenty of cannabis equities and related exchange traded funds will exit 2020 with their best performances in some time. It’s not just optimism surrounding the incoming Biden Administration and how the president-elect can affect marijuana stocks for the better. On Election Day, every state that had a medicinal, recreational or both initiative on the ballot said “yes.” That includes a group of deeply conservative and swing states, indicating attitudes toward legal cannabis are changing and no longer confined to the likes of California, Colorado and Washington. 7 Undervalued Stocks That Could Soar in 2021 With that in mind, here are the 7 best ETFs for marijuana bulls to buy right now:InvestorPlace - Stock Market News, Stock Advice & Trading Tips Alternative Harvest ETF  (NYSEARCA:MJ) AdvisorShares Pure US Cannabis ETF (NYSEARCA:MSOS) AdvisorShares Pure Cannabis ETF (NYSEARCA:YOLO) Amplify Seymour Cannabis ETF (NYSEARCA:CNBS) Cannabis ETF (NYSEARCA:THCX) Global X Cannabis ETF (NASDAQ:POTX) Cambria Cannabis ETF (CBOE:TOKE) While things are looking up for the U.S. cannabis market, there are still plenty of risky equities in the space, many with small price tags and even more diminutive upside prospects. In other words, stock picking in this arena is difficult, which explains why many investors prefer exchange traded funds. Best ETFs For Marijuana Bulls: Alternative Harvest ETF (MJ) Source: Shutterstock Expense ratio: 0.75% per year, or $75 for a $10,000 investment The Alternative Harvest ETF, the original ETF dedicated to marijuana stocks, is back in style as it recently marked $1 billion in assets under management. That’s a prestigious mark for any ETF, particularly a thematic fund like MJ. Although it’s still saddled with a double-digit year-to-date loss, MJ is proving sensitive to the aforementioned political tailwinds in the U.S., as the ETF now sports a fourth-quarter gain of 40.26%. More recently, MJ got a bit of boost on news of Aphria (NASDAQ:APHA) targeting rival Tilray (NASDAQ:TLRY) for a merger. Those two stocks combine for nearly 17% of MJ’s roster. With 82.1% exposure to the U.S., according to issuer data, MJ should benefit as cannabis laws here liberalize. However investors should scrutinize this exposure because the bulk of the fund’s biggest components aren’t U.S. growers. Rather they’re Canadian firms waiting on their moment south of the border. AdvisorShares Pure US Cannabis ETF (MSOS) Source: Shutterstock Expense ratio: 0.74% per year Speaking of exposure to U.S. growers, also known as multi-state operators (MSOs), the AdvisorShares Pure US Cannabis ETF is the first ETF with an explicit focus on the U.S. weed market. With its September 1 debut MSOS was the only new cannabis ETF to come to market this year, but it has proven investors want MSO allocations, as highlighted by $183.45 million in assets under management. That makes this one of the year’s most successful rookie thematic ETFs. Beyond that superlative, the new fund has confirmed the benefits of its domestic focus, returning 44.3% since inception. Plus, as an actively managed ETF MSOS dodges index constraints, allowing it to feature exposure U.S. growers, most of which trade over-the-counter (OTC). OTC stocks are usually ignored by traditional equity indexes. 7 Undervalued Stocks That Could Soar in 2021 In addition to a 58.4% weight to MSOs, the AdvisorShares ETF features exposure to six other industries, including real estate, financial services and cannabis pharmaceuticals producers. The fund is a solid idea for investors seeking smaller marijuana stock exposure, as mid and small caps combine for 86.8% of the roster. AdvisorShares Pure Cannabis ETF (YOLO) Source: Shutterstock Expense ratio: 0.75% per year The AdvisorShares Pure Cannabis ETF is the older stablemate to the aforementioned MSOS, and like its new counterpart, YOLO is actively managed. In fact, YOLO was the first actively managed weed ETF ever. While active fund managers consistently encounter difficulty beating benchmarks to justify their high fees, YOLO proves active management can and does work in the cannabis space, up 41.77% year-to-date. That performance is good enough to make YOLO one of best-performing marijuana ETFs, and flexibility is one of the reasons behind this fund’s impressive showing. YOLO allocates 61.5% of its weight to domestic marijuana stocks, including many of the OTC names dwelling in MSOS. But YOLO’s exposure to those names is synthetic and comes by way of derivatives. Dan Ahrens manages both MSOS and YOLO and “believes today’s new era can be viewed in similar regard to post-Prohibition, commencing a growing acknowledgement and understanding of cannabis and its uses among a mainstream audience. The industries that comprise the multi-billion dollar cannabis universe represent a new frontier, where proper caution and due diligence must be exercised surrounding its regulations and risks, in seeking attractive long-term cannabis investment opportunities,” according to AdvisorShares. Amplify Seymour Cannabis ETF (CNBS) Source: Shutterstock Expense ratio: 0.75% per year The Amplify Seymour Cannabis ETF is also actively managed, run by Seymour Asset Management’s Tim Seymour, a regular on CNBC’s “Fast Money” program. One benefit of CNBS, made evident by a 34.51% year-to-date gain that far outpaces passive rivals, is an emphasis on purity. This fund doesn’t hold derivative plays or tobacco stocks, only those that derive “80% of the portfolio companies with 50% or more of their revenue from the cannabis and hemp ecosystem,” according to the issuer. The bulk of CNBS’s holdings are retail, pharmaceuticals, cultivation firms or makers of cannabis-infused products or real estate names, as well as providers of agricultural technology or companies engaged in cannabis finance, technology and manufacturers of consumption devices. 7 Undervalued Stocks That Could Soar in 2021 CNBS holds 24 stocks, with $26.78 million in assets under management. The fund debuted in July 2019. Cannabis ETF (THCX) Source: Shutterstock Expense ratio: 0.70% per year The Cannabis ETF is one of the more cost-effective cannabis ETFs and a straightforward approach to the favorable regulatory environment setting up in the U.S., Mexico and other countries. And that much is reflected by fourth-quarter gains of 48% for THCX. “To put the opportunity into perspective, the global cannabis market is estimated to reach $630 billion by 2040 up from $12 billion today,” according to the issuer. THCX holds 29 stocks across eight industries with a median market capitalization of $204.2 million, indicating the fund tilts toward the smaller side of the marijuana stock universe. The fund features some exposure to British equities, but the U.S. and Canada are the markets that will chart the course for THCX. Global X Cannabis ETF (POTX) Source: Shutterstock Expense ratio: 0.50% per year The Global X Cannabis ETF, which tracks the Cannabis Index, has at least one thing in its favor: With annual fees of just 0.50%, it’s almost the least expensive fund in this category. POTX has a concentrated lineup of 18 stocks and, like many of its passive peers in this space, is heavily allocated to Canadian marijuana stocks. That country accounts for over 78% of the fund’s geographic exposure. To that end, POTX levered to growth north of the border and in the medicinal marijuana trade because pharmaceuticals and healthcare facilities combine for 93% of the ETF’s roster. The upside of that is some POTX components do offer investors avenues to growth in the U.S. and there is plenty of growth to be had in the cannabis market. 7 Undervalued Stocks That Could Soar in 2021 “Considering only ten years ago recreational cannabis was illegal in all 50 states, these results present a nationwide push to relax cannabis’ laws,” according to Global X research. “After these initiatives, 33% of the population will have access to legalized cannabis for adult use and 70% of all states have legalized cannabis for medical use.” Cambria Cannabis ETF (TOKE) Source: Shutterstock Expense ratio: 0.42% per year Two big things to like about the Cambria Cannabis ETF. First, it’s actively managed. Second, that annual fee of 0.42% is cheap by the standards of any actively managed fund, and the lowest in the cannabis ETF category. There’s another perk to TOKE being an active fund. It’s area of focus is micro-, mid- and small-cap stocks, groups that lend themselves to benefiting from active management in the marijuana stock landscape. TOKE’s lineup, though concentrated, is diverse at the industry level. Constituents include “companies across a range of market capitalizations that derive a significant portion of revenue from the legal sale, cultivation, production, or provision of cannabis-related products, services, or research,” according to Cambria. Bottom line: TOKE offers value for active management in an asset group where stock picking can be tricky for any investor. On the date of publication, Todd Shriber did not have (either directly or indirectly) any positions in any of the securities mentioned in this article. Todd Shriber has been an InvestorPlace contributor since 2014. More From InvestorPlace Why Everyone Is Investing in 5G All WRONG Top Stock Picker Reveals His Next 1,000% Winner Radical New Battery Could Dismantle Oil Markets The post The 7 Best ETFs For Marijuana Bulls To Buy Right Now appeared first on InvestorPlace.

Aurora Cannabis stock rallies after revising credit facility terms, Aurora Sun facility closure

Shares of Aurora Cannabis Inc. climbed 1.8% in premarket trading after the Canada-based cannabis company announced moves to bolster terms of its credit facility. The company said it reached agreement with its lenders to extend the maturity of its credit facility to Dec. 31, 2022, and transitioned the facility to a "minimum liquidity covenant" from a minimum Ebitda (earnings before interest, taxes, depreciation and amortization) covenant, which Aurora said provides it with "greater financial flexibility to execute the business transformation plan." As part of that plan, Aurora said it has closed its Aurora Sun facility and cut production at its Aurora Sky facility by 75%. "These hard decisions are being taken to improve cashflow and provide agility to our business," said Chief Executive Miguel Martin. The company also said it was shifting to a more variable cost structure, has expanded its network of external supply. The announcement comes as rivals Tilray Inc. and Aphria Inc. announced a merger to create the largest global cannabis company. Aurora's stock has plunged 60.6% year to date through Tuesday, while the ETFMG Alternative Harvest ETF has dropped 11.2% and the S&P 500 has gained 14.4%.

Tilray stock soars after 'reverse' merger deal with Aphria at a 23% premium

Shares of Tilray Inc. soared 30.8% in premarket trading and Aphria Inc.'s U.S.-listed stock surged 9.9%, after the Canada-based cannabis companies announced a merger, which they say will create the largest global cannabis company, with a combined equity value of about $3.9 billion. After the deal closes, which the companies said was structured has a "reverse acquisition" of Tilray, Aphria shareholders will own 62% of outstanding Tilray shares. The announcement comes after reports surfaced late Tuesday that the companies were in advanced merger talks. Under terms of the merger deal, Aphria shareholders will receive 0.8381 Tilray shares for each Aphria share they own, while Tilray shareholders will see no adjustment to their holdings. The "reverse acquisition" of Tilray represents a 23% premium to Tilray's stock closing price of $7.87 on Tuesday. Tilray's stock has tumbled 54.1% year to date through Tuesday, while Aphria shares have rallied 55.6%, the ETFMG Alternative Harvest ETF has lost 11.2% and the S&P 500 has gained 14.4%.

Canopy to close four indoor Canadian cannabis grow sites plus outdoor grow in Saskatchewan, cut 220 jobs

Canopy Growth Corp. said Wednesday it is ceasing operations at four of its Canadian sites and ending outdoor cannabis grow in Saskatchewan, in a move that will impact about 220 employees. "These actions will be an important step towards achieving our targeted $150-$200MM of cost savings and accelerating our path to profitability," Chief Executive David Klein said in a statement. "We are confident that our remaining sites will be able to produce the quantity and quality of cannabis required to meet current and future demand." The sites to be closed are St. John's, Newfoundland and Labrador; Fredericton, New Brunswick; Edmonton, Alberta; and Bowmanville, Ontario. The company is expecting to book pretax charges of $350 million to $400 million in the third and fourth quarters of fiscal 2021 to cover the costs of the moves. The sites are equal to about 17% of the company's indoor Canadian footprint and all of its outdoor footprint. U.S.-listed shares were down 0.7% but have gained 37% in the year to date, while the Cannabis ETF has gained 5% and the S&P 500 has gained 14%.

ETFMG Alternative Harvest ETF (MJ®) Exceeds $1 Billion in Assets Under Management

Leading thematic ETF issuer, ETF Managers Group LLC (ETFMG®), announced today that the ETFMG Alternative Harvest ETF, better known as MJ®, has again joined the "billion-dollar club." After less than 3 years of trading on the NYSE, MJ® achieved the impressive milestone of exceeding $1 billion assets under management (AUM) on December 4, 2020.

Why Cannabis Stocks & ETFs Are Soaring

Cannabis stocks and the ETFs have surged lately on hopes of the legalization of marijuana at the federal level under Biden presidency.

Stick With Canopy Growth Stock Below $30

Cannabis stocks have been on fire ever since Election Day 2020, with the ETFMG Alternative Harvest ETF (NASDAQ:MJ) rallying 45% since early November on the idea that a Joe Biden Presidency will pave the path for federal decriminalization and legalization of cannabis in the all important U.S. market. Leading this rally, of course, has been the cannabis industry’s biggest producer, Canopy Growth (NYSE:CGC). CGC stock has surged more than 50% since early November. Source: Shutterstock This optimism is not misplaced. It increasingly appears that the federal legalization of cannabis in the U.S. is a matter of “when”, not “if”. It also increasingly appears that with the right laws in place, legal markets across the globe can and will eventually attract demand away from the black market — and that this legal channel demand will inevitably be rather larger.InvestorPlace - Stock Market News, Stock Advice & Trading Tips Connecting those dots, the global stage is set for the long overdue pot stock boom to finally come to life over the next few years. As it does, CGC stock will stay in rally mode. Here’s a deeper look. Canada Turning a Corner For the last several years, cannabis stocks (right on down to Canopy Growth) have been crushed under the weight of lofty expectations. But now? The tide is turning, and cannabis is about to break through in a big way. 7 Hot Stocks Only Getting Hotter As Winter Approaches Just look to Canada, a country where cannabis market restrictions were eased to form an improved legal framework. That framework is finally pulling demand away from the black market and into the legal market. So what is Canada implementing differently? For starters, they’ve moved retail store openings from a “lottery system” to an “open licensing” model; brought cannabis derivatives, such as edibles and beverages, into the market to meet consumer demand; and slashed the price of legal pot beneath black market street prices. As a result, in the second quarter of 2020, Canada’s legal pot market has now bested its spending in the black market. U.S. Legalization on the Horizon At the same time, U.S. legalization efforts are starting to gain serious momentum. Of the five states with cannabis legalization on the ballot, all five passed it. Even conservative states such as Montana and Arizona have gotten in on the cannabis craze. What’s more, President-elect Joe Biden has signaled that his administration would federally decriminalize cannabis. That’s a significant step towards eventual nationwide legalization. If you’re keeping score, that means Canada’s legal cannabis market is on the cusp of finally coming into its own and the U.S. legal cannabis market is ready to come to life. The stage is set for this struggling industry to shift into hypergrowth, which bodes very well for Canopy Growth stock. Canopy Growth Is an Attractively Positioned Leader Canopy Growth is already the unrivaled leader in the global cannabis market, in terms of market value, sales, product distribution, and production volume. By itself, this early leadership position puts Canopy Growth is a great place to benefit from the rising cannabis tide over the next few years. But Canopy Growth is more than just big. The company also more resources than any other cannabis producer in the world to further extend its dominance. Early on, Canopy Growth leveraged its leadership position to score a huge investment from global alcoholic beverage giant Constellation Brands (NYSE:STZ). Thanks to that big investment, Canopy Growth has more than $1.3 billion in cash and short-term investments on its balance sheet. By comparison, most of Canopy’s peers as so cash strapped that they have major liquidity risks. Thus, Canopy’s big resource advantage means that as the global cannabis market booms over the next few years, Canopy will be able to invest in various emerging growth opportunities while its peers simply try to stay afloat. The result, of course, is that Canopy will be even more dominant player in the cannabis market in five years than the company is today. At the same time, Canopy Growth has taken big steps over the past few years in order to streamline operations, reduce its cost basis, and improve cash flows. This sets the stage for Canopy to be a more profitable producer going forward, meaning that big revenue growth in coming years will flow into big profits, too. Net net, Canopy Growth — and by extension, CGC stock — is attractively positioned to benefit from the coming pot stock boom. Canopy Growth Stock Has Upside Potential The last thing to address here is valuation. My numbers imply that CGC stock is fairly valued around $30 per today. Those numbers assume that the global cannabis market surges to be worth more than $50 billion by the end of the decade, Canopy Growth controls about 10% of that market, and operating margins rise to around 20% (which is roughly where they hover in the alcoholic beverage industry). Those are reasonable assumptions. Indeed, I’d say they are fairly conservative. The global cannabis market could march to $100+ billion in size by 2030. Canopy could control closer to 20% share. Operating margins could pan out around 30%. In other words, my $30 price target on CGC stock should be seen as a conservative price target. If a few things go right for this company, the stock is worth much more than $30. Bottom Line on CGC Stock For years, CGC stock has been a disappointment. That disappointment phase is now coming to a close. What comes next is the hypergrowth phase. During that phase, CGC stock will be a big winner. On the date of publication, Luke Lango did not have (either directly or indirectly) any positions in the securities mentioned in this article.  The New Daily 10X Stock Report: 98.7% Accuracy – Gains Up to 466.78%.  InvestorPlace’s brand-new and highly controversial newsletter is rocking the industry, delivering one breakthrough stock recommendation each and every trading day delivered straight to your inbox. 98.7% Accuracy to Date – Gains Up to 466.78%. Now, for a limited time, you can get in for just $19. Click here to find out how. More From InvestorPlace Why Everyone Is Investing in 5G All WRONG Top Stock Picker Reveals His Next 1,000% Winner Radical New Battery Could Dismantle Oil Markets The post Stick With Canopy Growth Stock Below $30 appeared first on InvestorPlace.

House votes yes to end federal cannabis prohibition

Yahoo Finance's Jessica Smith joins Kristin Myers to discuss the House's historic vote to decriminalize marijuana at a federal level.

Pot Stocks Get a Lift After a Symbolic Win From the UN

Marijuana stocks popped on Wednesday after a United Nations commission voted to remove cannabis from Schedule IV of the 1961 Single Convention on Narcotic Drugs, a list that includes heroin and fentanyl.

House to vote on bill to end federal cannabis prohibition

The U.S. House of Representatives is set to vote for the first time on ending the federal prohibition of cannabis. Yahoo Finance's Jessica Smith joins Kristin Myers to discuss.

Stock Market Today: Markets Climb on Election Cycle’s Penultimate Day

The broader stock markets rose Monday to kick off the month of November, but without much help from tech and tech-esque mega-caps.

Cannabis stocks surge after Trump administration sets formal transition in motion

Shares of cannabis companies rallied Tuesday, after the Trump administration made its first move late Monday to accept Joe Biden as president-elect by saying it was ready to begin the formal transition process. The ETFMG Alternative Harvest ETF surged 6.1% in premarket trading. It had shot up nearly 20% in the days following the election, on expectations Joe Biden will push for cannabis reform, then pulled back as President Trump continued to dispute the results. Among the more-active cannabis stocks in the premarket, the U.S.-listed shares of Aurora Cannabis Inc. soared 29.5%, Tilray Inc. shot up 19.2%, Canopy Growth Corp. climbed 7.6% and Cronos Group Inc. ran up 10.4%. The MJ ETF has rallied 26.5% so far this month through Monday, while the S&P 500 has advanced 9.4%.

Please let us know of any additional Marijuana Stock Tickers you would like to see! We will update this page regularly to follow all the latest news in the Cannabis sector.